GSK3B and breast cancer: To investigate whether adiponectin inadequacy could enhance beta-catenin signaling in mammary tumors, we examined the phosphorylation status of GSK3beta and its upstream protein kinase Akt, as well as the protein levels and nuclear activities of beta-catenin (Figure 7A).